Lactulose

DB00581ApprovedInvestigationalSmall moleculeAmmonia DetoxicantsLaxativesOsmotic Laxatives

Lactulose is a disaccharide derivative of lactose used to treat constipation and portal systemic encephalopathy. Despite being first synthesized in 1929, investigations regarding its possible use as a laxative for the treatment of chronic constipation did not occur until the 1960s and its first clinical use for treating PSE was...

Chemical structure of Lactulose
Mechanism
Curator reviewed · 1 reference
Primary indication
Lactulose is indicated for use as a laxative in the treatment of chronic constipation in adults and geriatric patients.Curator reviewed · 3 structured indications
Formula / weight
C12H22O11 · 342.2965 g/mol (avg)
First approval
Canada, 1999 · United States, 1966
Brand names
  • Constulose
  • Enulose
  • Generlac
  • Kristalose

Resolves to

Structure
InChIKeyJCQLYHFGKNRPGE-FCVZTGTOSA-NSMILESOC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O
Targets

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
686Drug interactionsStructured to mechanism, not free text
Sign in
108Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
2ContraindicationsEach with its own population and attribute set
Sign in
376Marketed productsAcross 10 countries and 154 labellers
Sign in
2ATC codesIncluding every combination product, plus 11 drug categories
Sign in
10+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Lactulose, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account